TY - JOUR
T1 - Topiramate for the treatment of Kleptomania
T2 - A case series and review of the literature
AU - Dannon, Pinhas N.
PY - 2003/1
Y1 - 2003/1
N2 - Kleptomania - the inability to resist the impulse to steal objects, not for personal use or monetary gain - is currently classified in psychiatric nomenclature as an impulse control disorder. There is no standard pharmacologic therapy for this disorder. If kleptomania was considered a form of obsessive-compulsive disorder, treatments used for this spectrum, including serotonin reuptake inhibitors (SSRI), other antidepressants, opioid receptor antagonist medications, and mood stabilizers, could be logically tested. Topiramate is currently used for the treatment of patients with affective and compulsive eating disorders. This report documents three kleptomanic patients who responded well to topiramate given either alone or in combination with SSRIs.
AB - Kleptomania - the inability to resist the impulse to steal objects, not for personal use or monetary gain - is currently classified in psychiatric nomenclature as an impulse control disorder. There is no standard pharmacologic therapy for this disorder. If kleptomania was considered a form of obsessive-compulsive disorder, treatments used for this spectrum, including serotonin reuptake inhibitors (SSRI), other antidepressants, opioid receptor antagonist medications, and mood stabilizers, could be logically tested. Topiramate is currently used for the treatment of patients with affective and compulsive eating disorders. This report documents three kleptomanic patients who responded well to topiramate given either alone or in combination with SSRIs.
KW - Impulse control
KW - Kleptomania
KW - Obsessive-compulsive spectrum
KW - SSRI
KW - Topiramate
UR - http://www.scopus.com/inward/record.url?scp=0037262273&partnerID=8YFLogxK
U2 - 10.1097/00002826-200301000-00001
DO - 10.1097/00002826-200301000-00001
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 12567156
AN - SCOPUS:0037262273
SN - 0362-5664
VL - 26
SP - 1
EP - 4
JO - Clinical Neuropharmacology
JF - Clinical Neuropharmacology
IS - 1
ER -